Asia/Oceania
The technology can in principle correct almost half of pathogenic mtDNA mutations, paving the way for mitochondrial disease modeling and therapeutic applications.
Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study
The initiative, called SG100K, plans to sequence and analyze the genomes of 100,000 Singaporeans to study Asian genomic diversity and Asian-specific diseases.
SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit
The test monitors cancer treatment response through shallow whole-genome sequencing of ctDNA and protein analysis.
Genes2Me Obtains CE Marking for Clinical Sequencing Panels
The panels, which were designed and have been validated for several common NGS platforms, cover oncology, pharmacogenomics, and hereditary diseases.
New Horizon Health, Prenetics to Launch Colorectal Cancer Test in Hong Kong, Macau, Taiwan
The companies first agreed to jointly commercialize the stool-based DNA test, which was developed by New Horizon, in late 2019.